Uttar Pradesh: As India continues to witness cases of adverse effects following COVID vaccination with majority complaining fever, headache and nausea, a 46-year-old ward boy from a district hospital in Uttar Pradesh’s Moradabad died within 24 hours after receiving the vaccine shot.
The ward boy, identified as Mahipal Singh, reportedly complained of breathlessness and unease in the chest after receiving a dose of Covishield, the COVID vaccine developed by Serum Institute of India.
“He (ward boy) was given the Covishield vaccine at about 12 PM on Saturday. A day later, he suffered pain in the chest with breathlessness. He had worked the night shift after vaccination and we don’t think the death is due to any side effect of the vaccine. We are trying to verify the exact reason for his death,” the chief medical officer (CMO) of the hospital was quoted as saying by Times of India.
On Sunday, Manohar Agnani, additional secretary of India’s Ministry of Health and Family Welfare said that nearly 447 adverse events following immunisation (AEFI) were reported after day 1 of the vaccination drive in India. He said only three required hospitalizations. The Government of India however hasn’t given any details about the adverse reactions happened for which particular vaccine.
A total of 2,24,301 healthcare workers have been inoculated with COVID vaccine.
India has approved two vaccines — Covaxin developed by Bharat Biotech and Covishield from the Oxford/AstraZeneca stable being manufactured by the Serum Institute of India — for emergency use in the country.